Document is current
Any future updates will be listed below
-
Authors
Yanagisawa, Hiroto
Kawabata, Hiroshi https://orcid.org/0000-0002-1918-8635
Ueda, Yusuke
Arita, Kotaro
Iwao-Kawanami, Haruka
Sakai, Tomoyuki
Kawanami, Takafumi
Yamada, Kazunori
Mizuta, Shuichi
Fukushima, Toshihiro
Masaki, Yasufumi
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (H29 Nanchi, etc. (Nan)-General-019, H27-28 Nanchi, etc. (Nan)-General-002, -008)
the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant No.17591060, 15K09510)
Kanazawa Medical University (Grant Nos. S2004-16, S2007-5, Grant No.K2011-7, Grant No.H2011-11, AR2012-06)
- License Information
-
More Information
Article History
Received: 8 November 2021
Revised: 28 February 2022
Accepted: 1 March 2022
First Online: 23 March 2022
Declarations
:
: YM received research grants from Kyowa Kirin Pharma, Astellas Pharma, Eisai Pharma, Ono Pharma, Pfizer Pharma, Asahi Kasei Pharma, MSD Pharma, Daiichi-Sankyo Pharma, Taisho Pharma, Taiho Pharma, Takeda Pharma, Chugai Pharma, Teijin Pharma, Nippon Kayaku, and Mochida Pharma, outside the submitted work. All other authors have no conflicts of interest.
